Hanna Sanoff is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 474 publications with 8,076 citations (h-index 42); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
The University Of North Carolina At Chapel Hl
Physicians Office Building, 170 Manning Dr., 3rd Floor
Chapel Hill, NC 275997305
Telephone
919-966-3856Registry record last updated 20 Jan 2016.
Clinical trials
- Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
- PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2012–2015 per NIH RePORTER. The latest:
- Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
Univ of North Carolina Chapel Hill
FY2015$170,100K07CA160722 - Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
Univ of North Carolina Chapel Hill
FY2014$170,100K07CA160722 - Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
Univ of North Carolina Chapel Hill
FY2013$170,100K07CA160722
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Nature Reviews Gastroenterology & Hepatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”